This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the Utixira Lotion + Utixira Lotion as regimen in healthy adult human subjects with dry or sensitive skin and prone to mild to moderate pruritus or urticaria
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
1. To evaluate the effectiveness of the test product in terms of change in Urticaria
Timeframe: after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
2. To evaluate the effectiveness of test product in terms of change in skin Pruritus (itching)
Timeframe: From baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
3. To assess the effectiveness of test product in terms of change in skin hydration
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
4. To assess the effectiveness of the test product in terms of change in DASI (Dry area and severity index) score
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
5. To assess the effectiveness of the test product in terms of change in overall dry skin score
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
6. To evaluate the effectiveness of the test product in terms of change in skin barrier function
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
7. To evaluate the effectiveness of the test product in terms of change in skin roughness
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
8. To evaluate the effectiveness of the test product in terms of change in skin scaliness
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
9. To evaluate the effectiveness of the test product in terms of change in skin smoothness
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)
10. To evaluate the effectiveness of the test product in terms of change in skin wrinkles
Timeframe: from baseline before usage of the test product on Day 01 and after usage of the test product at T2 hours on Day 01, Day 15 (+2 Days), and Day 30 (+2 Days)